Lukas Biomedical Inc.
Lukas Biomedical Inc. engages in the wholesale and retail of cosmetics in Taiwan. The company operates through E-Commerce Department, Medical Management Business, Cell Products Department, and Pharmaceutical Market Development Department segments. It also researches and develops immune cell medical technology for regenerative medicine and adjuvant treatment; engages in clinical trials; distribute… Read more
Market Cap & Net Worth: Lukas Biomedical Inc. (6814)
Lukas Biomedical Inc. (TWO:6814) has a market capitalization of $33.85 Million (NT$1.12 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #28454 globally and #1786 in its home market, demonstrating a -0.19% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lukas Biomedical Inc.'s stock price NT$26.75 by its total outstanding shares 41874000 (41.87 Million).
Lukas Biomedical Inc. Market Cap History: 2026 to 2026
Lukas Biomedical Inc.'s market capitalization history from 2026 to 2026. Data shows growth from $33.85 Million to $33.85 Million (0.00% CAGR).
Lukas Biomedical Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lukas Biomedical Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6814 by Market Capitalization
Companies near Lukas Biomedical Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to Lukas Biomedical Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Lukas Biomedical Inc. Historical Marketcap From 2026 to 2026
Between 2026 and today, Lukas Biomedical Inc.'s market cap moved from $33.85 Million to $ 33.85 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$33.85 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Lukas Biomedical Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $33.85 Million USD |
| MoneyControl | $33.85 Million USD |
| MarketWatch | $33.85 Million USD |
| marketcap.company | $33.85 Million USD |
| Reuters | $33.85 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.